- Home
- BLTE vs DAVA Comparison
BLTE vs DAVA Comparison
Compare BLTE & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- DAVA
- Stock Information
- Founded
- BLTE 2018
- DAVA 2000
- Country
- BLTE United States
- DAVA United Kingdom
- Employees
- BLTE N/A
- DAVA N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- DAVA EDP Services
- Sector
- BLTE Health Care
- DAVA Technology
- Exchange
- BLTE Nasdaq
- DAVA Nasdaq
- Market Cap
- BLTE 1.7B
- DAVA 2.0B
- IPO Year
- BLTE 2022
- DAVA 2018
- Fundamental
- Price
- BLTE $57.37
- DAVA $26.02
- Analyst Decision
- BLTE Strong Buy
- DAVA Buy
- Analyst Count
- BLTE 4
- DAVA 12
- Target Price
- BLTE $96.33
- DAVA $39.84
- AVG Volume (30 Days)
- BLTE 27.8K
- DAVA 390.3K
- Earning Date
- BLTE 03-10-2025
- DAVA 02-20-2025
- Dividend Yield
- BLTE N/A
- DAVA N/A
- EPS Growth
- BLTE N/A
- DAVA N/A
- EPS
- BLTE N/A
- DAVA 0.12
- Revenue
- BLTE N/A
- DAVA $950,741,765.00
- Revenue This Year
- BLTE N/A
- DAVA $10.84
- Revenue Next Year
- BLTE N/A
- DAVA $9.62
- P/E Ratio
- BLTE N/A
- DAVA $242.43
- Revenue Growth
- BLTE N/A
- DAVA N/A
- 52 Week Low
- BLTE $31.01
- DAVA $23.28
- 52 Week High
- BLTE $86.53
- DAVA $68.29
- Technical
- Relative Strength Index (RSI)
- BLTE 48.86
- DAVA 22.53
- Support Level
- BLTE $55.90
- DAVA $33.02
- Resistance Level
- BLTE $58.54
- DAVA $33.29
- Average True Range (ATR)
- BLTE 2.70
- DAVA 1.71
- MACD
- BLTE 0.24
- DAVA -0.79
- Stochastic Oscillator
- BLTE 52.14
- DAVA 4.46
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.